1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with sphingosine in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 7 (35.00) | 18.2507 |
| 2000's | 10 (50.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brady, RO; Brown, A; Comly, ME; Cooney, A; Goldin, E; Miller, SP; Pentchev, PG; Roff, CF; Vanier, MT | 1 |
| Felding-Habermann, B; Fenderson, BA; Hakomori, S; Handa, K; Igarashi, Y; Inokuchi, J; Park, LS; Radin, NS; Strassmann, G | 1 |
| Radin, NS; Vunnam, RR | 1 |
| Goto, I; Kobayashi, T; Sasagasako, N; Yamaguchi, Y | 1 |
| Hamanoue, M; Inokuchi, J; Kohsaka, S; Usuki, S | 1 |
| Inokuchi, J; Kuriyama, M; Mutoh, T; Tokuda, A | 1 |
| Hirabayashi, Y; Inokuchi, J; Ito, M; Ji, L; Yamagata, T; Zhang, G | 1 |
| Cryer, HG; Fu, M; Lo, CJ; Lo, FR | 1 |
| Fukunaga, T; Hatsuzawa, K; Nagahama, M; Tagaya, M; Tani, K; Yamamoto, A | 1 |
| Billups, C; Cabot, MC; Maurer, BJ; Melton, L; Reynolds, CP | 1 |
| Beckstrøm, KJ; Bettaïeb, A; Laurent, G; Lautier, D; Lehne, G; Maestre, N; Plo, I | 1 |
| Baccino, FM; Bonelli, G; Codogno, P; De Stefanis, D; Ghidoni, R; Isidoro, C; Reffo, P; Sala, G | 1 |
| Codogno, P; Dupré, T; Ghidoni, R; Sala, G; Seta, N | 1 |
| Colligan, PB; Relling, DP; Ren, J | 1 |
| Abe, A; Hiraoka, M; Shayman, JA | 1 |
| Hisaki, H; Kubota, M; Masuda, H; Nakagomi, T; Nakane, M; Shimasaki, H; Tamura, A; Ueta, N | 1 |
| Endo, H; Hanzawa, A; Kanegae, H; Matsumoto, K; Miyazawa, K; Nakabayashi, Y; Shinoda, H; Suda, Y; Suetsugu, M; Takano, A; Takeshita, A; Tanaka, S; Ueyama, Y; Yasui, T | 1 |
| Chatterjee, S; Kolmakova, A; Pili, R; Rajesh, M; Zang, D | 1 |
| Ahn, KH; Choi, JM; Jeon, HJ; Ji, JE; Jung, KM; Jung, SY; Kang, MS; Kim, DK; Kim, SK | 1 |
| Baran, Y; Kartal, M; Sahin, F; Saydam, G | 1 |
2 review(s) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and sphingosine
| Article | Year |
|---|---|
Type C Niemann-Pick disease: use of hydrophobic amines to study defective cholesterol transport.
Topics: Amines; Androstenes; Animals; Biological Transport; Cells, Cultured; Cholesterol; Cholesterol Esters; Disease Models, Animal; Fibroblasts; Filipin; Humans; Imipramine; Lysosomes; Mice; Morpholines; Niemann-Pick Diseases; Sphingosine; Structure-Activity Relationship | 1991 |
A turn in the road: How studies on the pharmacology of glucosylceramide synthase inhibitors led to the identification of a lysosomal phospholipase A2 with ceramide transacylase activity.
Topics: Acylation; Acyltransferases; Animals; Cattle; Ceramides; DNA, Complementary; Enzyme Inhibitors; Glucosyltransferases; Humans; Lysosomes; Mice; Molecular Structure; Morpholines; Phospholipases A; Phospholipases A2; Signal Transduction; Sphingosine | 2004 |
18 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and sphingosine
| Article | Year |
|---|---|
A ceramide analogue inhibits T cell proliferative response through inhibition of glycosphingolipid synthesis and enhancement of N,N-dimethylsphingosine synthesis.
Topics: Animals; Cell Division; Ceramides; DNA Replication; Gangliosides; Glycosphingolipids; Interleukin-2; Lymphocyte Activation; Mice; Mice, Inbred C3H; Morpholines; Phytohemagglutinins; Protein-Tyrosine Kinases; Receptors, Interleukin-2; Signal Transduction; Sphingosine; Stereoisomerism; T-Lymphocytes, Cytotoxic | 1990 |
Inhibitors of cerebroside metabolism.
Topics: Animals; Cerebrosides; Galactosylceramidase; Glucosylceramidase; Glucosyltransferases; Indicators and Reagents; Inositol; Morpholines; Propiophenones; Propylene Glycols; Sphingosine | 1981 |
The synthetic pathway for glucosylsphingosine in cultured fibroblasts.
Topics: Acylation; beta-Glucosidase; Cells, Cultured; Cerebrosides; Fibroblasts; Glucosylceramides; Glucosyltransferases; Glycosylation; Humans; Inositol; Morpholines; Psychosine; Sphingosine | 1994 |
Induction of ganglioside biosynthesis and neurite outgrowth of primary cultured neurons by L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol.
Topics: Animals; Carbon Radioisotopes; Cells, Cultured; Ceramides; Embryo, Mammalian; Enzyme Inhibitors; Female; Galactose; Gangliosides; Glycosphingolipids; Humans; Kinetics; Morpholines; Neurites; Neurons; Pregnancy; Radioisotope Dilution Technique; Rats; Rats, Wistar; Serine; Sphingomyelins; Sphingosine; Stereoisomerism; Tritium | 1996 |
Glucosylceramide synthase inhibitor inhibits the action of nerve growth factor in PC12 cells.
Topics: Animals; Cell Differentiation; Drosophila Proteins; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; Gangliosides; Glucosyltransferases; Glycosphingolipids; Insect Proteins; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Morpholines; Nerve Growth Factors; Neurons; PC12 Cells; Phosphatidylinositol 3-Kinases; Phosphorylation; Rats; Signal Transduction; Sphingosine | 1998 |
Effects of endoglycoceramidase or D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol on glucose uptake, glycolysis, and mitochondrial respiration in HL60 cells.
Topics: Cell Membrane Permeability; Cell Respiration; Glucose; Glycolysis; Glycoside Hydrolases; HL-60 Cells; Humans; Intracellular Fluid; Mitochondria; Morpholines; Oxidation-Reduction; Sphingosine | 1998 |
Macrophage TNF mRNA expression induced by LPS is regulated by sphingomyelin metabolites.
Topics: Animals; Ceramides; Endocannabinoids; Enzyme Inhibitors; Ethanolamines; Lipopolysaccharides; Macrophages, Alveolar; Male; Morpholines; Oleic Acids; Rabbits; RNA, Messenger; Sphingomyelins; Sphingosine; Tumor Necrosis Factor-alpha | 1999 |
Implication of sphingolipid metabolism in the stability of the Golgi apparatus.
Topics: Animals; Brefeldin A; Cattle; Cell Line; Ceramides; Coat Protein Complex I; Endocannabinoids; Endosomes; Enzyme Inhibitors; Ethanolamines; Golgi Apparatus; Masoprocol; Microscopy, Electron; Morpholines; Nocodazole; Oleic Acids; Sphingolipids; Sphingomyelin Phosphodiesterase; Sphingosine; trans-Golgi Network | 2000 |
Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Ceramides; Drug Synergism; Enzyme Inhibitors; Estrogen Receptor Modulators; Fenretinide; Glucosyltransferases; Humans; Morpholines; Necrosis; Neoplasms; Protein Kinase C; Sphingosine; Tamoxifen; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2000 |
Influence of ceramide metabolism on P-glycoprotein function in immature acute myeloid leukemia KG1a cells.
Topics: Acute Disease; Antigens, CD; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Ceramides; Daunorubicin; Drug Interactions; Gangliosides; Glucosylceramides; Humans; Lactosylceramides; Leukemia, Myeloid; Morpholines; Phosphorylation; Sphingosine; Tumor Cells, Cultured; Vincristine | 2002 |
Increase in ceramide level alters the lysosomal targeting of cathepsin D prior to onset of apoptosis in HT-29 colon cancer cells.
Topics: Amide Synthases; Apoptosis; Caspase Inhibitors; Caspases; Cathepsin D; Ceramides; Cytochrome c Group; DNA Fragmentation; Enzyme Inhibitors; Flow Cytometry; HT29 Cells; Humans; Immunoblotting; Lysosomes; Mitochondria; Morpholines; Nucleosomes; Sphingosine | 2002 |
Increased biosynthesis of glycosphingolipids in congenital disorder of glycosylation Ia (CDG-Ia) fibroblasts.
Topics: Animals; Antigens, CD; Carbohydrate Metabolism, Inborn Errors; Child; Child, Preschool; CHO Cells; Cricetinae; Cricetulus; Enzyme Inhibitors; Female; Fibroblasts; Glucosyltransferases; Glycoproteins; Glycosphingolipids; Glycosylation; Humans; Lactosylceramides; Male; Morpholines; Phosphotransferases (Phosphomutases); Protein Processing, Post-Translational; Sphingosine | 2002 |
Ceramide attenuates high glucose-induced cardiac contractile abnormalities in cultured adult rat ventricular myocytes.
Topics: Animals; Calcium; Calcium Signaling; Cells, Cultured; Enzyme Inhibitors; Glucose; Heart Ventricles; Male; Morpholines; Muscle Cells; Myocardial Contraction; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Sphingosine | 2002 |
In vivo influence of ceramide accumulation induced by treatment with a glucosylceramide synthase inhibitor on ischemic neuronal cell death.
Topics: Animals; Brain Ischemia; Cell Death; Ceramides; Disease Models, Animal; Enzyme Inhibitors; Gerbillinae; Glucosylceramides; Glucosyltransferases; Hippocampus; Male; Morpholines; Nerve Degeneration; Sphingosine | 2004 |
Sphingosine 1-phosphate acts as a signal molecule in ceramide signal transduction of TNF-alpha-induced activator protein-1 in osteoblastic cell line MC3T3-E1 cells.
Topics: 3T3 Cells; Animals; Blotting, Northern; Ceramides; Chemokine CCL2; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Gene Expression; Genes, fos; Genes, jun; Lysophospholipids; Mice; Mice, Inbred C57BL; Morpholines; Osteoblasts; Propanolamines; Pyrrolidines; Recombinant Proteins; Second Messenger Systems; Sphingomyelin Phosphodiesterase; Sphingosine; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2005 |
VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo.
Topics: Animals; Antigens, CD; Blotting, Western; Cell Line; Cell Line, Tumor; Chromones; Endothelial Cells; Female; Fibroblast Growth Factor 2; Galactosyltransferases; Glucosyltransferases; Humans; Lactosylceramides; Mice; Mice, Nude; Morpholines; Neovascularization, Physiologic; Phosphoinositide-3 Kinase Inhibitors; Phosphotransferases (Alcohol Group Acceptor); Platelet Endothelial Cell Adhesion Molecule-1; Receptors, Lysosphingolipid; Sphingosine; Suramin; Vascular Endothelial Growth Factor A | 2009 |
Hypoxia-induced neuronal apoptosis is mediated by de novo synthesis of ceramide through activation of serine palmitoyltransferase.
Topics: Apoptosis; Cell Hypoxia; Cell Line, Tumor; Ceramides; Endocannabinoids; Enzyme Inhibitors; Ethanolamines; Glucosylceramides; Glucosyltransferases; Humans; Morpholines; Neurons; Oleic Acids; Serine C-Palmitoyltransferase; Sphingosine | 2010 |
Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells.
Topics: Apoptosis; Ceramides; Down-Regulation; Glucosylceramides; Glucosyltransferases; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lysophospholipids; Morpholines; Phosphotransferases (Alcohol Group Acceptor); Resveratrol; RNA, Neoplasm; Sphingosine; Stilbenes; Up-Regulation | 2011 |